- Filed
- May 15, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2017 · May 14, 2017 | 899.19K sh |
| Shares Diluted | Q2 2017 · Mar 31, 2017 | 836.25K sh |
| Shares Diluted | Q2 2017 · Mar 31, 2017 | 835.89K sh |
| Shares Diluted | Q2 2017 · Mar 31, 2016 | 833.37K sh |
| Shares Diluted | Q2 2017 · Mar 31, 2016 | 833.01K sh |
| Capex | Q2 2017 · Mar 31, 2017 | $41K |
| Capex | Q2 2017 · Mar 31, 2016 | $134K |
| Cash And Equivalents | Q2 2017 · Mar 31, 2017 | $4.6M |
| Cash And Equivalents | Q2 2017 · Sep 30, 2016 | $3.17M |
| Cash And Equivalents | Q2 2017 · Mar 31, 2016 | $3.82M |
| Cash And Equivalents | Q2 2017 · Sep 30, 2015 | $2.53M |
| Stockholders Equity | Q2 2017 · Mar 31, 2017 | $11.77M |
| Stockholders Equity | Q2 2017 · Sep 30, 2016 | $11.85M |
| Stockholders Equity restated | Q2 2017 · Mar 31, 2016 | $11.78M |
| Stockholders Equity restated | Q2 2017 · Sep 30, 2015 | $11.71M |
| Total Liabilities | Q2 2017 · Mar 31, 2017 | $134.49M |
| Total Liabilities | Q2 2017 · Sep 30, 2016 | $128.15M |
| Total Assets | Q2 2017 · Mar 31, 2017 | $146.26M |
| Total Assets | Q2 2017 · Sep 30, 2016 | $139.99M |
| Eps Diluted | Q2 2017 · Mar 31, 2017 | −$0.10 |
| Eps Diluted | Q2 2017 · Mar 31, 2017 | −$0.10 |
| Eps Diluted restated | Q2 2017 · Mar 31, 2016 | $0.06 |
| Eps Diluted restated | Q2 2017 · Mar 31, 2016 | $0.09 |
| Eps Basic | Q2 2017 · Mar 31, 2017 | −$0.10 |
| Eps Basic | Q2 2017 · Mar 31, 2017 | −$0.10 |
| Eps Basic restated | Q2 2017 · Mar 31, 2016 | $0.06 |
| Eps Basic restated | Q2 2017 · Mar 31, 2016 | $0.09 |
| Net Income | Q2 2017 · Mar 31, 2017 | −$80K |
| Net Income | Q2 2017 · Mar 31, 2017 | −$87K |
| Net Income restated | Q2 2017 · Mar 31, 2016 | $46K |
| Net Income restated | Q2 2017 · Mar 31, 2016 | $79K |